Haplo-Cord Stem Cell Transplant for Aplastic Anemia
Part of Blood & lymphatic clinical trials.
This trial tests a new way of using a mix of donor stem cells (from a half-matched family member and a cord blood unit) to treat aplastic anemia, a condition where the bone marrow stops making enough blood cells. The goal is to see if this transplant approach is safe and helps rebuild healthy blood cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 14 years old.
- You must have been diagnosed with aplastic anemia (a type of bone marrow failure).
- You should be generally healthy enough for a stem cell transplant (good activity level, no major organ problems).
- You cannot have an active cancer, serious infection, or be pregnant or breastfeeding.
- You must be willing to follow the study plan and give your written permission to join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two first treatments for severe aplastic anemia: a half-matched (haploidentical) stem cell transplant versus immune-suppressing medicine. It is for people aged 14–70 who do not have a fully matched sibling donor.
This study tests whether adding umbilical cord blood to a stem cell transplant from a half-matched donor can improve outcomes for people with severe aplastic anemia or related bone marrow failure diseases.
This trial tests a new type of transplant using donated cord blood for adults with aplastic anemia that has not improved with standard treatments. It aims to see if the transplant is safe and effective.
This trial tests a stem cell transplant option for children or young adults with severe aplastic anemia that did not respond to prior immune-suppressing treatment. It uses a “half-matched” donor and gives post-transplant cyclophosphamide to help the donor cells work and reduce certain immune reactions.
This trial tests a new way to treat severe aplastic anemia by combining a stem cell transplant from a half-matched donor with special stem cells from umbilical cord blood. The goal is to help your body make healthy blood cells again.
This trial tests a special type of cord blood transplant using lab-grown stem cells to help the new blood-forming cells “take” sooner. It’s for people with severe aplastic anemia or certain MDS cases who have not responded well to standard immune-suppressing treatments.
Hear when a new Aplastic Anaemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.